Overall, SNHG6 and miR-181a were shown to directly interact with each, in which SNHG6 functions as an miR-181a decoy; furthermore, there was an overlap of downstream targets, specially involving the MAPK signaling pathway, whose aberrant activation has been previously described in NHL [63]. Here, SNHG6 is linked to non-Hodgkin lymphoma.